Yaz Plus Tablet (2018-07-12)
- Starting date:
- July 12, 2018
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-67522
Recalled Products
Yaz Plus Tablet
Reason
The dosage uniformity test is out of specification in the affected lots.
Depth of distribution
Wholesalers, Healthcare Establishments
Affected products
Yaz Plus Tablet
DIN, NPN, DIN-HIM
DIN 02387433
Dosage form
Tablet
Strength
DROSPIRENONE 3.00 MG
ETHINYL ESTRADIOL 0.02 MG
Levomefolate Calcium 0.451 MG
Levomefolate Calcium 0.451 MG
Lot or serial number
71010A
Companies
- Recalling Firm
-
Bayer Inc.
2920 MATHESON BLVD. EAST
MISSISSAUGA
L4W 5R6
Ontario
CANADA
- Marketing Authorization Holder
-
Bayer Inc.
2920 MATHESON BLVD. EAST
MISSISSAUGA
L4W 5R6
Ontario
CANADA